About BioHelix
BioHelix is a company based in Beverly (United States) founded in 2004 was acquired by Quidel in May 2013. The company has 22 employees as of December 31, 2013. BioHelix operates in a competitive market with competitors including Inscripta, Inflammatix, Karius, MeMed and Visby Medical, among others.
- Headquarter Beverly, United States
- Employees 22 as on 31 Dec, 2013
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biohelix Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioHelix
Investors in BioHelix
BioHelix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and QuidelOrtho.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
QuidelOrtho is engaged in providing diagnostic testing solutions globally.
|
Locked | Locked | Locked |
Investor details for BioHelix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioHelix
Investment portfolio details for BioHelix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioHelix
Detailed financials for BioHelix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biohelix Comparisons
Peer comparison for BioHelix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioHelix
BioHelix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inscripta, Inflammatix, Karius, MeMed and Visby Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
Detailed competitors of BioHelix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biohelix
Complete news archive for BioHelix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioHelix
BioHelix was founded in 2004 and raised its 1st funding round 5 years after it was founded.
BioHelix is headquartered in Beverly, United States. It is registered at Beverly, Massachusetts, United States.
As of Dec 31, 2013, the latest employee count at BioHelix is 22.
Biohelix, a spin-off from New England Biolabs, develops novel molecular diagnostic and research solutions using isothermal amplification technologies. It has a suite of proprietary technologies, including helicase-dependent amplification (HDA) using isothermal PCR, amplification technologies, and technology for whole-genome amplification that has been licensed from Harvard. Clinical diagnostic products include the instrument-free IsoAmp range of molecular assays for infectious diseases such as Bordetella, C. difficile, Group A and B Streptococcus, herpes (both HSV 1 2) and Trichomonas, as well as products for the detection of genetic diseases such as hereditary hemochromatosis and factor V Leiden. In addition, the company also specialized in life science research products such as the IsoAmp range of amplification kits for PCR, the PrimeNavigator series of extremely thermostable single-stranded DNA binding proteins, and thermostable mesophilic DNA helicases. In May 2013, Quidel acquired Biohelix for 10M upfront plus additional milestone payments.
BioHelix's top competitors include Visby Medical, Inflammatix and MeMed.
BioHelix has 2 investors. Key investors include HHS, and QuidelOrtho.